translate English to French: The anti-tumour activity of sorafenib can be attributed to the anti-proliferative and/or anti-neoangiogenic mechanism of action.
En plus des RTK, le sorafénib inhibe les sérine/thréonine kinases RAF intervenant dans la prolifération des cellules tumorales (CRAF, BRAF, V600E BRAF).